Skip to content

Perrigo Company PRGO Proceeds from royalty rights

Proceeds from royalty rights at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$6.98M+122%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$9M
Mercado Libre logo
Mercado LibreMELI
$18.75M
Staar Surgical logo
Staar SurgicalSTAA
$508K
Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$50K
Xencor logo
XencorXNCR
$0

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-62.9%
Enterprise value$4.82B-32.0%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept prgo:ProceedsFromRoyaltiesReceivedInvestingActivities.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's proceeds from royalty rights.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's proceeds from royalty rights?
Perrigo Company (PRGO) reported proceeds from royalty rights of $1.4M in Q1 2026.
How has Perrigo Company's proceeds from royalty rights changed year-over-year?
Perrigo Company's proceeds from royalty rights decreased by 17.6% year-over-year, from $1.7M to $1.4M.
What is the long-term trend for Perrigo Company's proceeds from royalty rights?
Over 2 years (2022 to 2024), Perrigo Company's proceeds from royalty rights has grown at a 25.5% compound annual growth rate (CAGR), from $3.3M to $5.2M.
What does proceeds from royalty rights mean?
Cash inflows derived from the licensing of intellectual property, patents, or other intangible assets. These proceeds represent a return on previous capital investments in research and development or business acquisitions. Monitoring this metric helps investors evaluate the long-term monetization potential of the company's intangible asset portfolio.